Cynaptec Pharmaceuticals
Stuart, US · Founded 2025 · Delaware corporation · 1 known investors
Founders & leadership
FS
FREDERICK SANCILIONamed on SEC filing
Board
JS
JONAH SHACKNAIBoard director
CF
CHARLES F GOULBURN IIBoard director
WR
WESLEY RAMJEETBoard director
SR
SETH RODNERBoard director
Investors · 1
Also in the syndicate · 1
Lobe Sciences Ltd.
Reported raises · per SEC filings
Form D private placements$6M disclosed across 1 of 2 rounds · 2025–2026
▶$6MraisedApr 2025 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedApr 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JONAH SHACKNAIDirector
- CHARLES F GOULBURN IIDirector
- WESLEY RAMJEETDirector
- FREDERICK SANCILIOExecutive Officer, Director
- SETH RODNERDirector
- Offering amount
- $26M
- Amount sold
- $6M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Cynaptec Pharmaceuticals raised?
- Cynaptec Pharmaceuticals has disclosed $6M raised across 1 of its 2 known rounds.
- Where is Cynaptec Pharmaceuticals headquartered?
- Cynaptec Pharmaceuticals is headquartered in Stuart, US.